Navidea Biopharmaceuticals Inc
OTC:NAVB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Navidea Biopharmaceuticals Inc
OTC:NAVB
|
US |
|
I
|
Inmobiliaria San Patricio SA
SGO:ISANPA
|
CL |
|
VIB Vermoegen AG
XETRA:VIH1
|
DE |
|
S
|
Shaanxi Jinye Science Technology and Education Group Co Ltd
SZSE:000812
|
CN |
|
Genting Singapore Ltd
SGX:G13
|
SG |
|
KABE Group AB
STO:KABE B
|
SE |
|
I
|
IAT Automobile Technology Co Ltd
SZSE:300825
|
CN |
|
AUB Group Ltd
ASX:AUB
|
AU |
|
Alpha FX Group PLC
LSE:AFX
|
UK |
|
GIFT Holdings Inc
TSE:9279
|
JP |
|
Sonoco Products Co
NYSE:SON
|
US |
|
H
|
High Coast Distillery AB (publ)
STO:HIGHCO B
|
SE |
|
PB Fintech Ltd
NSE:POLICYBZR
|
IN |
|
A
|
Aerowash AB (Publ)
F:1HV
|
SE |
|
C
|
Chemical Industries (Far East) Ltd
SGX:C05
|
SG |
|
D
|
Doctorglasses Chain Co Ltd
SZSE:300622
|
CN |
|
I
|
Indexa Capital Group SA
MAD:INDXA
|
ES |
|
C
|
Crest Group Bhd
KLSE:CREST
|
MY |
Profitability Summary
Navidea Biopharmaceuticals Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.
Profitability Score
Margins
Earnings Waterfall
Navidea Biopharmaceuticals Inc
Margins Comparison
Navidea Biopharmaceuticals Inc Competitors
| Country | Company | Market Cap |
Gross Margin |
Operating Margin |
Net Margin |
||
|---|---|---|---|---|---|---|---|
| US |
|
Navidea Biopharmaceuticals Inc
F:NO1A
|
4.6m EUR |
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
373.2B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.4B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.9B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD |
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
69.6B AUD |
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Return on Capital
Return on Capital Comparison
Navidea Biopharmaceuticals Inc Competitors
| Country | Company | Market Cap | ROE | ROA | ROCE | ROIC | ||
|---|---|---|---|---|---|---|---|---|
| US |
|
Navidea Biopharmaceuticals Inc
F:NO1A
|
4.6m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
373.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
190.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
69.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
